Ahmar U. Zaidi, MD: As far as preventive therapies go, hydroxyurea is the mainstay of therapy in sickle cell disease. And hydroxyurea is quite an interesting drug that has been studied very ...

Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The average time on hydroxyurea was 5 years, with many children on the therapy for ...

SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in patients with hemoglobin SC, a milder form of sickle cell disease (SCD), a ...

Please provide your email address to receive an email when new articles are posted on . Despite it being the standard of care for treating vasocclusive disease associated with sickle cell disease, ...

Children with sickle cell disease had improved lung function after treatment with hydroxyurea, according to a study presented at the American Thoracic Society (ATS) 2016 International Conference.

Hydroxyurea may falsely elevate sensor glucose results from certain CGM systems. The prescribing information for hydroxyurea has been updated to include information regarding patients who use ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with sickle cell disease (SCD), according to new research published in Blood ...

A nurse at Mulago conducts a review on a sickle cell patient. The World Sickle Cell Awareness Day is observed annually with the goal of increasing public knowledge and a understanding of the disease, ...

A 73-year-old man with a history of chronic myelogenous leukemia presented with multiple ulcers on both legs (Figure 1). The ulcers were extremely painful. The patient had no history of diabetes or ...

Patients with GBM at any recurrence received imatinib mesylate plus hydroxyurea (500 mg twice a day) orally on a continuous, daily schedule. The imatinib mesylate dose was 500 mg twice a day for ...